Self‐reported clinical features and treatment effectiveness of Papillon–Lefèvre syndrome patients from five Latin American countries: A cross‐sectional online survey study
Australasian Journal of Dermatology · 2024
DOI: 10.1111/ajd.14219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2024. Verfasst von Daniela Alfaro-Sepúlveda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile. Hauptthemen laut MEDLINE: Self Report, Quality of Life, Papillon-Lefevre Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background/Objectives Most studies about Papillon–Lefèvre syndrome (PLS) are limited to case reports and patients of the same nationality. This study aimed to determine the self‐reported prevalence of signs, symptoms and treatment effectiveness in PLS patients from five Latin American countries.
Methods
An online survey was conducted among adult and paediatric patients from Mexico, Argentina, Colombia and Brazil. Data were collected using multiple‐choice, open‐ended and image‐chooser questions on demographics, signs and symptoms, perceived treatment effectiveness and quality of life.
Results
Seventeen patients (10 males and 7 females) aged 4–47 years were surveyed. All had palmoplantar hyperkeratosis. Other affected sites were the feet and hand dorsum (82.35%), Achilles tendon (88.24%), forearms (58.82%), legs (29.41%) and glutes (23.53%). They frequently presented hyperhidrosis and nail pitting. Four had a history of delayed umbilical cord separation. All used topical treatments, with moderate effectiveness; half used oral retinoids, perceived as highly effective. Most reported decreased quality of life and walking difficulties.
Conclusions
The study's results align with prior research on PLS, but reveal new insights, including the impact on patients' quality of life and a history of delayed umbilical cord separation. These findings warrant consideration in future research and patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile.
- Faculty of Medicine, Universidad de Chile, Santiago, Chile.
- Department of Dermatology, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
- Department of Dermatology, Clínica Universidad de los Andes, Santiago, Chile.
- Department of Dermatology, Clínica MEDS, Santiago, Chile.
- Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
ORCID-Profile: Daniela Alfaro-Sepúlveda, Fernando Valenzuela, Valentina Burckhardt-Bravo
Zitieren
APA
Alfaro-Sepúlveda, D., Salinas, P. P., Valenzuela, F., Gonzalez, C. G., Burckhardt-Bravo, V., & Ferrari-Sande, D. (2024). Self‐reported clinical features and treatment effectiveness of Papillon–Lefèvre syndrome patients from five Latin American countries: A cross‐sectional online survey study. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14219
Vancouver
Alfaro-Sepúlveda D, Salinas PP, Valenzuela F, Gonzalez CG, Burckhardt-Bravo V, Ferrari-Sande D. Self‐reported clinical features and treatment effectiveness of Papillon–Lefèvre syndrome patients from five Latin American countries: A cross‐sectional online survey study. Australasian Journal of Dermatology. 2024. doi:10.1111/ajd.14219
BibTeX
@article{AlfaroSeplveda2024,
author = {Alfaro-Sepúlveda, Daniela and Salinas, Pía Parra and Valenzuela, Fernando and Gonzalez, Carmen Gloria and Burckhardt-Bravo, Valentina and Ferrari-Sande, Dominga},
title = {Self‐reported clinical features and treatment effectiveness of Papillon–Lefèvre syndrome patients from five Latin American countries: A cross‐sectional online survey study},
journal = {Australasian Journal of Dermatology},
year = {2024},
doi = {10.1111/ajd.14219}
}
EUVIMED